Alternative Preservation Strategies of Donation After Circulatory Death Hearts: Effect of Cold Ischemia Time Before Normothermic Machine Perfusion Authors: Manuela Lopera Higuita, Emmanuella O. Ajenu, Maya Bolger‐Chen, George Olverson, Soheila Ali Akbari Ghavimi, Si Young Lee, Taku Kasai, William Michaud, Chukwudi Chijioke, Bhuban Ruidas, Allison Pitti, Nathan Minie, Joseph Catricala, Doug Vincent, Selena Li, David D'Alessandro, Elena Aikawa, Sasha A. Singh, Marie Billaud, Asishana A. Osho, Shannon N. Tessier, S. Alireza Rabi Published: 2026 ABSTRACT BackgroundDonation after circulatory death (DCD) offers a promising strategy to expand the donor pool by 20% to 30%. However, DCD heart grafts experience warm ischemia injury, making effective graft viability assessment before transplantation prudent. Current methods for assessing DCD hearts are impacted by either ethical concerns and regional limitations (thoracoabdominal normothermic regional perfusion) or the need for significant resources, expertise, and equipment, with limitations in functional assessment (direct procurement and reperfusion, via the Organ Care System by TransMedics). This study explores an alternative preservation approach using controlled hypothermia followed by normothermic machine perfusion for graft evaluation.MethodsDCD grafts were procured from porcine donors after 19 minutes of functional warm ischemia. Hearts were preserved using controlled hypothermic static storage at 4 °C to 8 °C for up to 7 hours, followed by reanimation with normothermic machine perfusion. Graft viability was evaluated using a novel ex vivo cardiac loading method. Outcomes were compared with DCD grafts reperfused immediately after procurement.ResultsNo significant functional, biochemical, or proteomic differences were observed between DCD cardiac grafts preserved via controlled hypothermia for up to 7 hours and those reperfused immediately after procurement.ConclusionsControlled hypothermia may be a viable alternative to current DCD preservation methods, eliminating ethical concerns of thoracoabdominal normothermic regional perfusion and reducing logistical complexity and costs associated with direct procurement and reperfusion. These findings provide a foundation for a potential shift in DCD heart preservation practices, offering a more effective and cost‐efficient approach to expand the donor pool and improve transplantation outcomes. Nonstandard Abbreviations and Acronyms cold ischemia time controlled cold storage preservation donation after circulatory death direct procurement and perfusion functional warm ischemia time Gene Ontology gene set enrichment analysis normothermic machine perfusion warm ischemia time Research PerspectiveWhat Is New? Novel Preservation Paradigm This study proposes controlled hypothermic storage (4°C–8 °C) followed by normothermic machine perfusion for donation after circulatory death hearts, challenging the need for immediate reperfusion. Unlike direct procurement and reperfusion, this strategy allows device‐free transport and reanimation at the recipient center, reducing logistical complexity and expanding geographic sharing. Hearts maintained metabolic fitness and contractile function after 12 hours ex vivo, including 7 hours of hypothermic storage. What Question Should Be Addressed Next? Translational Implications Critical questions remain about the long‐term impact of suppressed structural and metabolic proteins, and ultimate graft performance postimplantation. Future studies should focus on transplant outcomes to confirm whether controlled hypothermic storage followed by normothermic machine perfusion can safely and effectively extend preservation windows and improve utilization of donation after circulatory death hearts in clinical practice. Research Perspective What Is New? Novel Preservation Paradigm This study proposes controlled hypothermic storage (4°C–8 °C) followed by normothermic machine perfusion for donation after circulatory death hearts, challenging the need for immediate reperfusion. Unlike direct procurement and reperfusion, this strategy allows device‐free transport and reanimation at the recipient center, reducing logistical complexity and expanding geographic sharing. Hearts maintained metabolic fitness and contractile function after 12 hours ex vivo, including 7 hours of hypothermic storage. This study proposes controlled hypothermic storage (4°C–8 °C) followed by normothermic machine perfusion for donation after circulatory death hearts, challenging the need for immediate reperfusion. Unlike direct procurement and reperfusion, this strategy allows device‐free transport and reanimation at the recipient center, reducing logistical complexity and expanding geographic sharing. Hearts maintained metabolic fitness and contractile function after 12 hours ex vivo, including 7 hours of hypothermic storage. This study proposes controlled hypothermic storage (4°C–8 °C) followed by normothermic machine perfusion for donation after circulatory death hearts, challenging the need for immediate reperfusion. Unlike direct procurement and reperfusion, this strategy allows device‐free transport and reanimation at the recipient center, reducing logistical complexity and expanding geographic sharing. Hearts maintained metabolic fitness and contractile function after 12 hours ex vivo, including 7 hours of hypothermic storage. What Question Should Be Addressed Next? Translational Implications Critical questions remain about the long‐term impact of suppressed structural and metabolic proteins, and ultimate graft performance postimplantation. Future studies should focus on transplant outcomes to confirm whether controlled hypothermic storage followed by normothermic machine perfusion can safely and effectively extend preservation windows and improve utilization of donation after circulatory death hearts in clinical practice. Critical questions remain about the long‐term impact of suppressed structural and metabolic proteins, and ultimate graft performance postimplantation. Future studies should focus on transplant outcomes to confirm whether controlled hypothermic storage followed by normothermic machine perfusion can safely and effectively extend preservation windows and improve utilization of donation after circulatory death hearts in clinical practice. Critical questions remain about the long‐term impact of suppressed structural and metabolic proteins, and ultimate graft performance postimplantation. Future studies should focus on transplant outcomes to confirm whether controlled hypothermic storage followed by normothermic machine perfusion can safely and effectively extend preservation windows and improve utilization of donation after circulatory death hearts in clinical practice. Heart failure is a chronic, progressive condition expected to affect >8 million people in the United States alone by 2030, 1 with heart transplantation remaining the only definitive cure for end‐stage heart failure. 2 However, broad access is significantly limited by the critical shortage of organ donors. 3 Various strategies have been explored to expand the donor pool, with donation after circulatory death (DCD) showing particular promise, as the utilization of DCD grafts has the potential to increase the organ donor pool by 20% to 30%. 4 DCD hearts undergo a mandatory period of warm ischemia time (WIT) after the withdrawal of life support and during the donor's progression to death. During this period, coronary perfusion pressure is insufficient to deliver adequate oxygen to the myocardium, leading to ischemia and possible dysfunction, necessitating assessment of graft viability before implantation. Two methods are currently used to assess DCD hearts post‐WIT: thoracoabdominal normothermic regional perfusion and direct procurement and perfusion (DPP). 5 Assessment via thoracoabdominal normothermic regional perfusion involves placing postmortem donors on cardiopulmonary bypass while excluding cerebral circulation to avoid brain reperfusion. 6 After graft reanimation and a stabilization period, extracorporeal support is gradually removed, and the cardiac graft is evaluated using standard assessment tools. 6 Following evaluation, viable organs are subsequently transported using static cold storage or normothermic machine perfusion (NMP). 7 In addition to aiding in graft assessment, thoracoabdominal normothermic regional perfusion is suggested to improve posttransplant outcomes by mitigating the effects of warm ischemia, as adenosine triphosphate levels are restored and ischemic preconditioning may be activated. 8 Despite this advantage and being arguably more cost‐effective than DPP, 9 ethical concerns have hindered the widespread application of this assessment method, with some regions even imposing moratoriums. 10 , 11 Alternatively, assessment via DPP involves rapid graft procurement following WIT, with subsequent reanimation on a commercially available NMP platform. The beating hearts are then transported by airplane to recipient centers, and during this travel period, their viability is assessed on the basis of lactate trends and visual inspection. 12 The immediate reperfusion via NMP limits cold ischemia and perfuses the heart with warm, oxygenated blood supplemented with nutrients. 13 , 14 Furthermore, this technique enables some degree of ex vivo functional assessment through maintenance of the beating heart. 15 However, the implementation of DPP requires significant expertise, logistical coordination, and resources, which may be prohibitive for some transplant centers. 13 , 16 Furthermore, although the Organ Care System is the only US Food and Drug Administration–approved NMP platform and is widely utilized, it lacks robust functional assessment capabilities. This is because the hearts are perfused in a nonworking, unloaded, Langendorf mode, and its primary quantitative metric, lactate levels, has proven to be an unreliable predictor of heart function. 17 Despite its limitations, DPP remains the predominant method for DCD heart preservation and assessment in the United States and globally. 18 At the core of the DPP paradigm is the assumption that DCD hearts require immediate normothermic reperfusion to minimize further ischemic episodes and preserve graft viability. 19 However, the absolute necessity of immediate normothermic reperfusion remains unproven, with limited direct evidence supporting the superiority of bypassing hypothermic preservation altogether. 20 , 21 , 22 On the contrary, emerging data suggest that a period of controlled hypothermia before NMP may improve graft function and reduce injury, as demonstrated in a rodent model of DCD heart transplantation, where grafts were exposed to oxygenated hypothermic perfusion following warm ischemia and before NMP. 23 Similarly, another study demonstrated that exposure to hypothermia attenuated the burst of free radicals and oxidative stress associated with reperfusion injury in rodent hearts. 24 The cardioprotective effects of hypothermia before reperfusion have also been well supported in the myocardial infarction literature. Decades of experimental and clinical evidence (previously reviewed 25 , 26 ) have shown that controlled hypothermia before reperfusion reduces reperfusion injury and dampens the inflammatory response, effectively preconditioning the myocardium for normothermic reperfusion. A similar trend has been observed in lung transplantation, where moderate hypothermic preservation (6°C–10 °C) has been associated with improved graft function and posttransplant outcomes. 27 , 28 The significant improvement in preservation technologies has enabled a more controlled hypothermic storage compared with the traditional static cold storage on ice. These emerging techniques allow us to maximize the possible protective effects of hypothermia without the potential harmful effects of ice storage. As a result, transporting DCD hearts in static controlled hypothermia followed by NMP at the recipient center may offer distinct advantages over the current DPP strategy. This preservation method reduces the logistical complexity and cost associated with portable perfusion devices and in‐transit NMP. Moreover, it enables more sophisticated functional assessments at the receiving transplant center, including cardiac loading protocols that offer a more comprehensive evaluation of graft viability before implantation. 29 To evaluate the plausibility of this preservation/assessment method, this study used a porcine model of donation after circulatory death, where grafts were procured and stored for up to 7 hours in controlled hypothermia using the Paragonix SherpaPak system. Following storage, grafts were reanimated via NMP and assessed via a novel loaded perfusion mode, which simulates near‐physiological conditions. 29 Grafts were then evaluated via a comprehensive array of biochemical, proteomic, imaging, and functional tests. This study sets a precedent for potentially shifting the current DCD heart preservation paradigm away from either thoracoabdominal normothermic regional perfusion and DPP and toward a more effective and less costly approach. Methods All research complies with the ethical standards and regulations set forth by National Research Council guidelines and in the experimental protocol 2023N000042 approved by the Institutional Animal Care and Use Committee of Massachusetts General Hospital (Boston, MA) and the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines. The authors declare that all supporting data are available within the article and its online Supplementary Files. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE 30 partner repository with the data set identifier PXD067097 and https://doi.org/10.6019/PXD067097. Porcine Model of Donation After Circulatory Death Yorkshire pigs (weight, 30–35 kg; age, 3–4 months; mixed sex) were anesthetized and intubated, with anesthesia maintained using inhaled isoflurane (3%–5%) and intravenous fentanyl (5–20 μg/kg per hour) as needed. After the full depth of anesthesia was confirmed, midline sternotomy was performed. Systemic heparin (300 U/kg) was administered and allowed to circulate for 3 minutes. A cardioplegia needle was placed in the ascending aorta. A pressure sensor was connected to a side channel of the cardioplegia cannula and used to continuously monitor the mean arterial pressure. Once proper pressure monitoring was confirmed, the animals were transitioned to intravenous anesthesia, ventilation was turned off, and the animals were allowed to expire secondary to apnea. Once the mean arterial pressure decreased below 30 mm Hg, functional WIT (fWIT) was initiated and observed for a total of 19 minutes, during which circulatory arrest occurred. The 19‐minute fWIT duration was selected on the basis of average WIT values reported in the United Network for Organ Sharing registry, derived using data analysis methods described in previous publications. 31 After 19 minutes of fWIT, 1 L of blood is collected from the right atrium to be used during normothermic perfusion. The left and right atria were vented, cross clamp was placed distal to the cardioplegia cannula, and the heart was flushed with 1 L of del Nido cardioplegia solution at 4 °C. Hearts preserved via controlled hypothermic storage before NMP were then flushed with an additional liter of University of Wisconsin solution, also at 4 °C. Following the flush, cardiotomy was performed in a standard manner. Hearts were either immediately instrumented for placement on the NMP system (minimal cold ischemia time [CIT]; n=6) or stored using controlled static hypothermic preservation in 3 to 4 L of University of Wisconsin solution within the Paragonix SherpaPak (Waltham, MA) for 5 hours (5 hours controlled cold storage preservation [cCSP]; n=7) or 7 hours cCSP (n=6; Figure 1). Hearts stored under cold ischemia conditions were subsequently instrumented for placement on the ex vivo perfusion platform. Experimental setup and design. Donation after circulatory death was imitated by allowing pigs to expire attributable to apnea after ventilatory arrest. Once an MAP of 30 mm Hg was reached, a functional WIT was maintained for a total of 19 minutes. Because of the low MAP (30 mm Hg) and its downward trend at the initiation of the 19‐minute timer, all animals reached circulatory arrest at varying times but within the 19‐minute period. Hearts were either reperfused immediately via normothermic machine perfusion for evaluation or stored via cCSP for 5 or 7 hours. Once storage time was completed, cCSP hearts were reperfused via normothermic machine perfusion for evaluation. cCSP indicates controlled cold storage preservation; MAP, mean arterial pressure; and WIT, warm ischemia time. Heart Instrumentation The left atrial (LA) vent site was sutured closed with 4–0 Prolene continuous suture, pacing wires were attached to the myocardium, and a double purse string suture was placed around the LA cuff to allow sealing and achieve LA pressurization during loaded mode perfusion. The aorta was cut below the arch, and an aortic cannula (VentriFlo Inc, Pelham, NH) was inserted and fastened with a zip tie. The hearts were weighted, and full‐thickness, 5‐mm biopsy punches were obtained from the right ventricle for downstream analysis. Ex Vivo Perfusion Platform The ex vivo perfusion system, as well as the Langendorf and loaded perfusion methods, used in this study have been described in detail elsewhere. 29 Briefly, the system is composed of an organ chamber (VentriFlo Inc, Pelham, NH) connected to a reservoir, which is, in turn, connected to a pediatric oxygenator (Terumo Medical Corporation, Somerset, NJ) via a pulsatile pump (VentriFlo Inc). During Langendorf perfusion, the oxygenator is supplied with oxygenated perfusate from a Windkessel bag (VentriFlo Inc), which is connected directly to the aorta. During loaded perfusion, the oxygenator fills a secondary reservoir (loading reservoir), which is used to pressurize the LA. Heart Perfusion All chemicals were purchased from Sigma Aldrich unless otherwise stated. All hearts were retrogradely perfused for 1 hour, followed by 3 hours in loaded mode in the aforementioned system. Hearts were perfused with 2 L of base perfusate containing 0.96% Krebs–Henseleit buffer, 9.915 mM dextran, 25 mM sodium bicarbonate, 1.054 mM bovine serum albumin, 1% penicillin–streptomycin (1000 U/mL), 0.13% insulin (100 U/mL), 0.02% hydrocortisone (50 mg/mL), 0.5% heparin (1000 U/mL), 2.75 mM calcium chloride, and 1 L of isolated red blood cells (1:2), warmed at 37 °C by the circulation of warm water (Adroit Medical Systems, Loudon, TN) through the double jacket of the oxygenator and oxygenated with 100% O2. Isolated red blood cells were obtained via cell saver processing (Medtronic, Dublin, Ireland) of the whole blood collected during surgery, followed by filtration through a leukoreduction filter (Haemonetics, Boston, MA). Hearts were continuously administered adenosine (333 μg/min) delivered via a syringe pump connected to the system as close as possible to the organ. After instrumentation, hearts were connected to the perfusion system, maintaining an aortic pressure between 35 and 40 mm Hg. Hearts were rhythmically massaged to avoid left ventricular (LV) distention until intrinsic contractions were detected. In case of fibrillation, hearts were defibrillated (Hewlett Packard, Louisville, KY) starting with 10 J, with subsequent shocks administered in increments of 10 J until rhythmicity was observed. A back‐up pacer was set at 60 beats per minute. Once stable conditions were achieved, 3 ECG leads were placed on the surface of the hearts, and the resulting signal was transferred to the pulsatile pump to achieve counterpulsation between the pump and the heart. Hearts were perfused in retrograde mode for 1 hour (Figure S1). Loaded Mode Perfusion To achieve loaded mode (Figure S1B), the loading reservoir was filled until a pressure between 12 and 14 mmHg was achieved. The loading pressure was maintained solely by controlling the fluid height in the loading reservoir, leading to passive left atrial pressurization (ie, gravity‐dependent pressurization). 29 A right‐angle metal tip cannula (Medtronic) was inserted into the LA with the opening pointing toward the appendage to avoid obstruction of the mitral valve. Along with the canula, a fiber optic pressure sensor (304 μm OD; Opsens, Canada) was inserted through the opening of the LA cuff and into the left ventricle for LV pressure recording. The LA cuff was closed around the canula and pressure sensor to create a seal by tightening the previously placed purse string sutures through snares. In the loaded mode perfusion implemented in this study, pump outflow is completely redirected toward the loading reservoir, resulting in a passive afterload (ie, perfusion of the coronaries and the mean arterial pressure is solely dependent on LV ejection without mechanical pump assistance). 29 Viability Assessment Oxygen and lactate measurements were quantified from perfusate samples via a blood gas analyzer (Siemens Medical Solutions, Malvern, PA) every 30 minutes. Oxygen uptake rate was determined as described previously. 32 Hearts were weighed before and after perfusion, and these values were used to calculate percentage weight gain, a proxy for edema. Mitochondria oxidation‐reduction state during perfusion was quantified via Raman resonance spectroscopy (Pendar Technologies, Cambridge, MA), as extensively described elsewhere. 33 Briefly, the device uses a 441‐nm laser to measure Raman resonance photons from the left ventricle, with data collected over 180 seconds. A custom LabView software subtracts the fluorescence baseline and applies a regression algorithm to demultiplex the spectrum, using a library of chromophore spectra (mitoreduced, mito‐oxidized, and myoglobin) to analyze the data. The regression calculates the relative concentrations of metabolic molecules, allowing the determination of the proportion of reduced mitochondria/total mitochondria. The energetic status of cardiac cells was calculated via the energy charge of the adenylate system following the formula: (adenosine triphosphate+0.5*adenosine diphosphate)/(adenosine triphosphate+adenosine diphosphate+adenosine monophosphate). 34 The metabolic cofactors (adenosine triphosphate, adenosine monophosphate, and adenosine diphosphate) were obtained via mass spectrometry, as described previously. 35 Briefly, biopsy punches obtained from the right ventricle before and after perfusion were flash frozen in liquid nitrogen and stored at −80 °C. Flash‐frozen tissue was homogenized and analyzed using a 3200 triple quadrupole liquid chromatography–mass spectrometry system (AB Sciex, Toronto, Canada). Mitochondria morphology was assessed from electron microscopy images. Preperfusion and postperfusion samples (1 × 1 mm) were fixed for several hours at room temperature in 2.0% paraformaldehyde/2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4), then incubated in fresh fixative overnight at 4 °C. Specimens were rinsed several times in 0.1 M cacodylate buffer, incubated for 1 hour in 1% osmium tetroxide, rinsed again multiple times in cacodylate buffer, then dehydrated through a graded series of ethanol incubations until reaching 100%, followed by a 10‐minute dehydration in 100% propylene oxide. Tissue was then transferred into a 2:1 mix of propylene oxide:Eponate resin (Ted Pella, Redding, CA), incubated for 2 hours at room temperature, then placed into a 1:1 mix of propylene oxide:Eponate resin, incubated overnight at room temperature on a gentle rotator. The following day, specimens were transferred into fresh 100% Eponate and incubated for several hours on a gentle rocker table, then embedded in flat molds with fresh 100% Eponate resin and allowed to polymerize in a 60 °C oven (24–48 hours). Ultrathin (70‐nm) sections were cut using a Leica EM UC7 ultramicrotome, collected onto formvar‐coated grids, stained with 2% uranyl acetate and Reynold's lead citrate, and examined in a JEOL JEM 1011 transmission electron microscope at 80 kV. Once processed, 10 to 15 images per sample (n=3 per CIT) were acquired using a Tecnai G2 Spirit BioTWIN transmission electron microscope (FEI, Hillsboro, OR) equipped with a Nanosprint 43‐MKII camera (Advanced Microscopy Techniques, Woburn, MA). The mitochondria on each image were counted, and their length and width were quantified via ImageJ. 36 Average mitochondrial counts were manually scored in randomly selected fields. Mitochondrial dimensions, including length and width, were selectively measured, and viability was assessed on the basis of intact membranes and clearly defined cristae. Histologic images were obtained from before and after punch biopsies fixed in 4% paraformaldehyde (ThermoFisher, Waltham, MA) in PBS for 1 hour, rinsed twice with PBS, transferred to 70% ethanol, and embedded in paraffin. Embedded samples were cut and stained with hematoxylin and eosin stain. Functional Assessment Vascular resistance was calculated by dividing the coronary pressure by coronary flow rate and corrected for preperfusion graft weight. LV output pressure was acquired from the fiber optic pressure sensor inserted into the left ventricle during loaded mode perfusion and continuously recorded using Labscribe software (iWorx, Dover, NH), and the data were processed with MATLAB (MathWorks Inc, Natick, MA). Heart rate was calculated by counting the number of peaks per second from the LV pressure recordings and multipying by 60 to obtain beats per minute. Atrial and aortic pressures and flows were recorded every 30 minutes and used to calculate the loadability metric. Proinflammatory Assessment Proinflammatory markers were measured via bead‐based immunoassay (Luminex, Austin, TX), by Eve Technologies Corp (Alberta, CA). Briefly, inflow perfusate samples were collected at 30 minutes and 4 hours, centrifuged at 2200 rpm for 10 minutes to separate the red blood cells, and the acellular perfusate was flash frozen and shipped on ice for processing. Analysis was performed using a Luminex 200 system, following the kit's manufacturer instructions (MilliporeSigma, Burlington, MA). Proteolysis Protein lysates were prepared as described below on myocardium from the left and right ventricles harvested before and after NMP in hearts reperfused immediately after harvesting (minimal CIT) and after storage and after NMP for hearts stored in cold conditions for 5 or 7 hours (cCSP). A total of 44 samples were processed. Protein extraction was performed on ice using a lysis buffer consisting of radioimmunoprecipitation assay buffer (Thermo Scientific, catalog number 89900), phenylmethylsulfonyl fluoride (1 mM, MP Biomedicals), protease inhibitor cocktail (Sigma Aldrich), and phosphatase inhibitor cocktail (Thermo Scientific). A total of 44 myocardial specimens from the left and right ventricles were cut into 2‐ to 4‐mm pieces, mixed with lysis buffer (1 mL for 300 mg of tissue), and mechanically dissociated using the GentleMACS Dissociator (Protein01 program, Miltenyi Biotech). After centrifugation (100 g, 3 minutes, 4 °C), the tissue lysates were transferred to microcentrifuge tubes and underwent 5 freeze–thaw cycles. Lysates were further centrifuged (500 g, 5 minutes, 4 °C), and a fraction of the supernatant was stored for future analyses while the other was recentrifuged (21 300 g, 20 minutes, 4 °C). The protein concentration of the resulting fraction was determined using a bicinchoninic acid assay (Thermo Fisher Scientific), according to the manufacturer's instructions. Protein lysates were stored at −80 °C until peptide preparation. The lysates were proteolyzed using the iST in‐solution digestion kit (PreOmics GmbH, Germany) automated on the PreON robot (PreOmics): 10 μg protein in 10 μL was added to 40 μL LYSE buffer (PreOmics). The samples were trypsinized for 3 hours following the manufacturer's instructions. Eluted peptides were dried in a speed vacuum (EppendorfVacufuge) and resuspended in 40 μL Liquid Chromatography‐load. Mass Spectrometry Mass spectra were acquired on Orbitrap Fusion Lumos coupled to an Easy‐nLC1000 high‐performance liquid chromatography pump (Thermo Fisher Scientific). The peptides from 44 samples were diluted 5‐fold using LC‐load and 4 μL injections separated using a dual column setup: an Acclaim PepMap 100 C18 high‐performance liquid chromatography column, 75 μm×70 mm (Thermo Fisher Scientific, catalog number 164946); and an EASY‐Spray high‐performance liquid chromatography column, 75 μm ×250 mm (Thermo Fisher Scientific, catalog number ES902). The column was heated at a constant temperature of 45 °C. The gradient flow rate was 300 nL/min from 5% to 21% solvent B (0.1% formic acid in acetonitrile) for 75 minutes, 21% to 30% solvent B for 15 minutes, and another 10 minutes of a 95% to 5% solvent B sawtooth wash. Solvent A was 0.1% formic acid in mass spectrometry–grade water. The mass spectrometer was set to 120 000 resolution, and the top N precursor ions in a 3‐second cycle time (within a scan range of m/z 400–1500; isolation window, 1.6 m/z) were subjected to collision‐induced dissociation (collision energy, 30%) for peptide sequencing. Mass Spectral Analyses The acquired peptide spectra corresponding to the 44 samples were searched with Proteome Discoverer package (Version 2.5) using the SEQUEST‐HT search algorithm against the Sus Scrofa (pig) Uniprot fasta database (downloaded March 19, 2024; n=22 784 entries). The digestion enzyme was set to trypsin, and up to 2 missed cleavages were allowed. The precursor tolerance was set to 10 ppm, and the fragment tolerance window was set to 0.6 Da. Methionine oxidation and N‐terminal acetylation were set as dynamic modifications, and cysteine carbamidomethylation was set as a static modification. The peptide false discovery rate was calculated by the Proteome Discoverer package Percolator algorithm, and peptides were filtered on the basis of a false discovery rate threshold of 1.0%. Unique peptides were used to assign the master protein, and razor peptides were included for quantification. A minimum of 2 unique peptides for each protein were required for the protein to be included in the analyses. The Feature Mapper was enabled in Proteome Discoverer package to quantify peptide precursors detected in the mass spectrometry 1 but may not have been sequenced in all samples. Chromatographic alignment was performed with a maximum retention time shift of 10 minutes, mass tolerance of 10 ppm, and signal/noise minimum of 5. Precursor peptide abundances were based on their chromatographic intensities, and total peptide amount was used for Proteome Discoverer package normalization. After exporting the data from Proteome Discoverer, a median normalization step was applied using a custom script in Python to fill missing quantification values with “0” and rescale the data. Statistical Analysis Values identified as physiologically implausible or inconsistent with expected instrument performance were classified as outliers and excluded on the basis of documented measurement or instrumental artifacts. All results used 6 hearts in minimal CIT, 7 hearts in 5 hours, and 6 hearts in 7 hours groups unless otherwise indicated in the results section. Over‐time data were analyzed using repeated‐measures 2‐way ANOVA and Tukey–Kramer honestly significant difference post hoc analysis on standard least squares means. Column data were analyzed via nonparametric bootstrapping (10 000 iterations). Two‐sided P values were calculated as the proportion of bootstrap replicates exceeding observed differences. Analyses were implemented in Python, and P‐value convergence was monitored across iterations. Inflammatory marker data were analyzed via the Difference‐in‐Differences test. To do so, it was assumed that in the absence of treatment with cCSP, the 2 groups of hearts will have similar changes in the inflammatory cytokine production during NMP. Therefore, any differences seen in the cytokine accumulation during NMP is attributed to 1 group being subject to cCSP. Statistical significance is defined as P < 0.05. For the purpose of robust power, we combined all the hearts preserved with cCSP under one group and compared them with the minimal CIT group. All data are expressed as median±interquartile range. Statistical significance is defined at P<0.05. Perseus v 2.1.3 was used for group comparison of protein abundance after log2 transformation of protein abundances. 37 The quality of the data set was ensured by plotting the frequency distribution of each protein abundance into a histogram for each sample. The Student t‐test was used to calculate significantly different proteins between 2 groups (minimal CIT versus CSP and poststorage versus postperfusion) at a permutation‐based false discovery rate (false discovery rate or adjusted q‐value) threshold of ≤0.05. The false discovery rate was estimated using a permutation‐based approach, in which sample group labels were randomly reassigned 250 times to simulate the null hypothesis and generate a null distribution of test statistics. Volcano plots were generated using the results of the Student t test. Principal component analyses were performed on complete proteomes, whereas hierarchical clustering was performed on proteins found to be significantly different by Student t test. Gene Ontology analysis was performed in DAVID (https://davidbioinformatics.nih.gov/summary.jsp) on proteins found to be significantly differentially expressed between groups. 38 Gene set enrichment analysis (GSEA) was performed using GSEA v4.4.0 and Molecular Signatures Database indicated in the Supplemental Tables. 39 , 40 These enrichment analyses were performed as hypothesis‐generating tools to identify biological pathways and processes potentially associated with the observed molecular changes. RESULTS Controlled Hypothermic Preservation of DCD Grafts Before NMP Does Not Affect Graft Metabolism or Function Immediate NMP is the bedrock of the DPP method of preserving DCD hearts, with the assumption that any period of cold ischemia between procurement and normothermic reperfusion is deleterious to the graft function. 19 However, the results in this study, along with a few other recent publications, 20 , 21 , 22 challenge this assumption by demonstrating the function of DCD cardiac grafts is retained after hypothermic storage (Figures 2 and 3). Conventional assessment metrics of graft viability. Metrics are considered conventional if their acquisition is possible during unloaded (eg, Organ Care System) perfusion. A, In perfusate inflow (checkered columns) and outflow lactate (solid columns) measured over time for minimal CIT, 5‐hour cCSP, and 7‐hour cCSP. B, Lactate consumption (OutFlow ‐ InFlow). C, Coronary vascular resistance. D, Oxygen uptake rate. E, Heart rate, obtained from intraventricular pressure recordings. Solid line indicates the median of the experimental replicates, and the shaded area indicates interquartile range. F, AUC of heart rate data for every half an hour of perfusion. Column data presented as median±interquartile range. Wilcoxon/Kruskal‐Wallis test with Dunn post hoc analysis on medians. Repeated‐measures 2‐way ANOVA and Tukey–Kramer HSD post hoc analysis on standard least squares means. AUC indicates area under the curve; cCSP, controlled cold storage preservation; CIT, cold ischemia time; and HSD, honestly significant difference. *P<0.05, **P≤0.01, ***P≤0.001. Nonconventional assessment metrics: LVPP. Metrics are considered nonconventional if their acquisition is only possible via left ventricular loading and not common practice clinically. A, Maximum systolic pressure over time, denoted as LVPP of minimal CIT (1‐hour CIT), 5‐hour cCSP, and 7‐hour cCSP. Solid line indicates median of the experimental replicates, and the shaded area indicates interquartile range. B, AUC of the LVPP for every half an hour of perfusion. C, Cardiac muscle contractility quantified from the maximum derivative of the pressure pulse. D, Cardiac muscle relaxation quantified from the minimum derivative of the pressure pulse. E, Ejection fraction. F, Global longitudinal strain obtained from epicardial echocardiographic data. Column data presented as median±interquartile range. Wilcoxon/Kruskal‐Wallis test with Dunn post hoc analysis on medians. Repeated measures 2‐way ANOVA and Tukey–Kramer HSD post hoc analysis on standard least squares means. AUC indicates area under the LVPP curve; CIT, cold ischemia time; cCSP, controlled cold storage preservation; HSD, honestly significant difference; and LVPP, left ventricular pulse pressure. Both conventional (eg, available during unloaded perfusion, as in the Organ Care System platform) and nonconventional (eg, functional assessment requiring LV loading) metrics were used to assess graft metabolic fitness and function. An overall increase in lactate was seen in grafts in all groups (Figure 2A), with the final concentration of lactate (4 hours) in minimal CIT and 5 hours cCSP grafts being statistically higher than initial lactate levels (30 minutes). Alternatively, although still experiencing a progressive increase in lactate over time, the final lactate levels (4 hours) of 7‐hour cCSP grafts were not statistically higher than levels at the beginning of perfusion (30 minutes). Lactate consumption (outflow–inflow; Figure 2B) and vascular resistance (Figure 2C) demonstrated no significant difference between groups or within groups over time. Similarly, no changes over time were observed in the oxygen uptake rate or between groups (Figure 2D). Likewise, no statistically significant differences in heart rate (Figure 2E and 2F) were observed either over the course of perfusion or between groups. Despite the slight variability in conventional assessment metrics, nonconventional, functional metrics of graft viability were similar across all groups. No statistical differences were seen in LV pulse pressure (systolic–diastolic; Figure 3A and 3B), cardiomyocyte contractility (Figure 3C), or relaxation (Figure 3D) over time or between groups. Although ejection fraction was significantly lower (~20%) than normal (50%–70%), 41 likely because of the nonphysiological characteristics of the perfusion system, no differences in ejection fraction (Figure 3E) or global longitudinal strain (Figure 3F), obtained via epicardial echocardiography, were seen across groups immediately after LV loading and after 4 hours of perfusion. Moderate Hypothermic Preservation Before NMP Does Not Adversely Affect Myocardial Structure or Ultrastructure In addition to biochemical and functional assessments, myocardial structural integrity can serve as a marker of preservation quality. Extended cold ischemia on ice has been associated with cellular and ultrastructural damage. 42 No structural abnormalities were observed in hearts preserved at 6 °C to 8 °C for 5 or 7 hours before NMP, as determined in hematoxylin and eosin–stained tissue, with visibly normal cardiomyocyte size, regular striations, uniform nuclei, and normal interstitial spacing (no storage‐induced edema) present in the right ventricle regardless of CIT (Figure 4A). Slight disruptions are present after NMP in both the right (Figure 4B) and the left (Figure 4C) ventricle of the cardiac grafts in all groups, with visibly increased irregularities and variability in cardiomyocyte orientation, cytoplasmic vacuolation, sporadic disruptions to striations, as well as the presence of red blood cells in the interstitial spaces, potentially indicating vascular congestion. Additionally, widening of the intermyocyte spaces translated into weight gain, a proxy for edema, at the end of the 4 hours of perfusion (Figure 4D). Minimal CIT grafts experienced a 33.81% (10%–46.67%) weight increase, 5 hours cCSP grafts showed a 45.91% (19.9%–56.8%) weight increase, and 7 hours cCSP grafts exhibited a 33.37% (19.9%–47.62%) weight increase, with no statistical difference between the groups regardless of CIT (P=0.214; Figure 4D). The lack of differences in histologic results across groups, both poststorage and postperfusion, as well as in the quantified postperfusion edema, indicates that these adverse changes are a direct effect of the NMP. Effects of cold ischemia storage and NMP in myocardial structure and edema. A, Representative H&E‐stained images of the right ventricular wall poststorage. Representative H&E‐stained images of the right (B) and left (C) ventricular walls postperfusion. Scale bar = 100 μm. D, Percentage weight gain after 4 hours of perfusion. Column data presented as median±interquartile range. Wilcoxon/Kruskal‐Wallis test with Dunn post hoc analysis on medians. CIT indicates cold ischemia time; cCSP, controlled cold storage preservation; H&E, hematoxylin and eosin; and NMP, normothermic machine perfusion. Mitochondrial Ultrastructure, Oxidation‐Reduction State, and Myocardial Energy Stores Are Preserved Following Moderate Hypothermic Preservation Mitochondria are central regulators of myocardial injury during ischemia and reperfusion, with their health and structure directly influencing the extent of tissue damage. 43 , 44 No mitochondrial ultrastructural abnormalities were observed in transmission electron microscopy images in hearts preserved at 4 °C to 8 °C for 5 or 7 hours compared with those reperfused immediately (minimal CIT) with regular size/shape, densely packed, and organized cristae and intact mitochondrial membranes (Figure 5A). Similarly, no ultrastructural changes were seen after 4 hours of perfusion (Figure 5B). Mitochondrial morphology, including length (Figure 5C) and width (Figure 5D), as well as the number of viable mitochondria (Figure 5E) remained unchanged, with no significant differences between groups in either poststorage or postperfusion samples. The retention of mitochondria ultrastructure, shape, and viability resulted in retained mitochondrial function, with no statistical differences between groups in mitochondria oxidation‐reduction state (Figure 5F), although statistically more reduced mitochondria (higher ratio of reduced mitochondria/total mitochondria) were seen in minimal CIT grafts at 3 hours of perfusion when compared with earlier time points. Similarly, no significant difference was observed in energy charge between groups at either time point (Figure 5G), with preperfusion and postperfusion right ventricular samples showing comparable energy content irrespective of CIT. These findings indicate that moderate hypothermic preservation does not impair mitochondrial function or reduce myocardial energy reserves, supporting the overall structural, ultrastructural, and metabolic integrity of DCD hearts before NMP. Mitochondrial ultrastructure, redox state, and energy stores. TEM representative images of right ventricular tissue poststorage (A) and postperfusion (B). Scale bar = 600 nm. Mitochondria length (C), width (D) and percent viability (E) were quantified by measuring 20 to 25 mitochondria per TEM image of 3 biological replicates. Data points from each biological replicate are represented by different symbols. Solid columns indicate poststorage measurements, and checkered columns indicate postperfusion measurements. F, Over time, mitochondrial redox state with 3RMR determining the percentage of reduced mitochondria. G, Adenylated energy charge of right ventricular tissue poststorage (solid columns) and postperfusion (checkered columns). Column data presented as median±interquartile range. Wilcoxon/Kruskal‐Wallis test with Dunn post hoc analysis on medians. Repeated‐measures 2‐way ANOVA and Tukey–Kramer HSD post hoc analysis on standard least squares means. 3RMR indicates ratio of reduced mitochondria/total mitochondria; CIT, cold ischemia time; cCSP, controlled cold storage preservation; HSD, honestly significant difference; redox, oxidation‐reduction; and TEM, transmission electron microscopy. *P<0.05. Controlled Hypothermic Preservation Before NMP Selectively Attenuates the Release of Selective Cytokines; NMP Induces a Robust Inflammatory Response in DCD Hearts Previous studies have demonstrated that recipients of DCD hearts preserved via NMP experience increased episodes of acute rejection and hospitalization posttransplant. 45 Although the underlying mechanisms remain unclear, ischemia–reperfusion injury is known to trigger a potent inflammatory response that can influence graft tolerance and rejection. 46 Despite the storage time (ie, longer cold ischemia exposure), cardiac grafts exposed to controlled hypothermia for 5 or 7 hours do not experience an additional increase in inflammatory response immediately after reperfusion (30 minutes) when compared with cardiac grafts reperfused after minimal hypothermic storage (T0 minimal CIT versus T0 cCSP; Figure 6). On the contrary, the accumulation of interleukin‐1 receptor antagonist (Figure 6A; P=0.003) and interleukin‐12 (Figure 6F; P=0.032) after 4 hours was significantly lower, whereas interleukin‐1β trended toward significance (Figure 6C; P=0.073) in the controlled hypothermia group, suggesting a blunted inflammatory response. Notably, both proinflammatory (interleukin‐1 receptor antagonist and interleukin‐10) and anti‐inflammatory (interleukin‐1β, interleukin‐6, interleukin‐8, and interleukin‐12) cytokines increased significantly over perfusion time in both groups (all P<0.001), whereas interleukin‐18 did not show a significant time‐dependent increase. These results indicate a robust inflammatory response mediated by NMP. Proinflammatory and anti‐inflammatory markers immediately after reperfusion (T0; 30 minutes) and after 4 hours of NMP (T4). To increase statistical power, cytokine analysis was limited to 2 groups: minimal CIT and cCSP. In perfusate, concentration of anti‐inflammatory (A and B) and proinflammatory (C–G) cytokines at 30 minutes (T0) and 4 hours (T4) of perfusion time. Median is represented by red line. Data analyzed via difference‐in‐difference test. CIT indicates cold ischemia time; cCSP, controlled cold storage preservation; IL, interleukin; IL‐1RA, IL‐1 receptor antagonist; and NMP, normothermic machine perfusion. *P<0.05. Controlled Hypothermic Preservation Does Not Alter the Myocardial Proteome Before or After NMP Preservation strategies and prolonged ischemia are known to influence the epigenetic programming of cellular stress responses, which can manifest through transcriptomic and proteomic changes. Although some effects may be apparent immediately after reperfusion, structurally, ultrastructurally, or functionally, others may impact graft performance later, particularly postimplantation. Proteomic analysis offers an early window into these molecular changes. Principal component analysis of the proteome profile of the right ventricle shows overlap between nonstored grafts (minimal CIT) and those stored via cCSP poststorage/preperfusion (Figure 7A), and no significant differentially abundant proteins were found (Figure 7D). Similarly, no differences in the proteome profiles were detected in either the right (Figure 7B and 7E) or the left (Figure 7C and 7F) ventricle between minimal CIT grafts and cCSP grafts after 4 hours of NMP, with the exception of CYFIP‐related Rac1 interactor A, which is upregulated after NMP in the right ventricle. Overall, these results indicate that controlled hypothermia does not significantly affect the proteome profile of DCD grafts. Effect of CIT on the myocardium proteome. To increase statistical power, proteomic analysis was limited to 2 groups: minimal CIT and cCSP. Each dot on the PCA graphs represents a biological replicate. Among the poststorage cCSP samples, n=6 were 5‐hour cCSP and n=2 were 7‐hour cCSP. Among the postperfusion cCSP samples, n=5 were 5‐hour cCSP and n=5 were 7‐hour cCSP. PCA (A–C) and volcano plots (D–F) were generated from the proteome profiles of poststorage RV and postperfusion RV and LV. CIT indicates cold ischemia time; cCSP, controlled cold storage preservation; LV, left ventricle; PCA, principal component analysis; and RV, right ventricle. Alternatively, NMP seems to cause a differential effect in the proteome irrespective of storage, with postperfusion proteome profiles (open circles) of both minimal CIT (Figure 8A) and cCSP (Figure 8B) visibly clustering in distinct groups versus their respective poststorage profiles (filled circles). Interestingly, however, exposure to controlled hypothermia seems to alter the magnitude of the effect on the proteome, with minimal CIT grafts differentially expressing only 51 proteins (Figure 8C, Table S1, and Figure S2), whereas 324 proteins were differentially expressed in cCSP grafts (Figure 8D, Table S2, and Figure S3). Of the 51 differentially expressed proteins in minimal CIT grafts, 39 are also differentially expressed in cCSP grafts. Effect of NMP on myocardium proteome profiles. To increase statistical power, proteomic analysis was limited to 2 groups: minimal CIT and cCSP. Each dot on the PCA graphs represents a biological replicate. Among the poststorage cCSP samples, n=6 were 5‐hour cCSP and n=2 were 7‐hour cCSP. Among the postperfusion cCSP samples, n=5 were 5‐hour cCSP and n=5 were 7‐hour cCSP. PCA (A and B) and volcano plots (C and D) were generated from the proteome profiles of RV poststorage and postperfusion. The PCA graphs show that postperfusion (open circles) proteome profiles cluster in distinct groups when compared with their respective poststorage (filled circles) profiles, indicating changes in proteome caused by NMP. Volcano plots revealed 51 differentially expressed proteins before and after perfusion of minimal CIT grafts (C), and 324 differentially expressed proteins poststorage/preperfusion and postperfusion of grafts stored in cCSP (D), as determined by Student t‐test and multiple adjustment by permutation‐based false discovery rate. The gray line represents the line of significance for a false discovery rate of 0.05 and a fold change cutoff of 0.1. CIT indicates cold ischemia time; cCSP, controlled cold storage preservation; NMP, normothermic machine perfusion; PCA, principal component analysis; RV, right ventricular. Qualitative Gene Ontology analysis was performed on the 51 and 324 proteins whose abundance was affected by NMP in minimal CIT and cCSP grafts, respectively. In minimal CIT grafts, NMP mostly affected proteins annotated with Gene Ontology (GO) terms related to circulating proteins (eg, extracellular space/region and vitamin transport) erythrocytes (eg, iron ion transport, oxygen binding, and platelets [eg, platelet degranulation and complement activation]; Figure 8E, Table S3). Similarly, the proteins primarily affected by NMP as minimal CIT grafts were annotated with Pathways terms related to red blood cell pathways (platelet degranulation, platelet activation, hemostasis, and O2/CO2 uptake; Figure 8E, Table S4). For hearts stored in cCSP, NMP resulted in an overrepresentation of proteins annotated with GO terms and pathways related to plasma, erythrocytes, and platelets (Figure 8F, Tables S5 and S6). However, NMP in cCSP hearts also affected proteins related to inflammation (innate immune system and regulation of toll‐like receptor by endogenous ligand), the mitochondria (mitochondrial inner membrane, aerobic respiration, and respiratory electron transport), and myocyte cytoskeleton (Z disc and actin filament binding; Figure 8F, Tables S6 and S7). GO and Pathways term enrichment analysis on a small amount of differentially expressed proteins may lack statistical power. Therefore, a GSEA was performed, which considers ranked gene expression data and may provide more robust insights in this context, especially for the minimal CIT grafts. GSEA showed that NMP primarily affects proteins related to ribosomal activity, transporter activity, and mitochondria in minimal CIT grafts (Figure 8G, Table S7). The top 15 canonical pathways affected by NMP in these hearts were related to translation, metabolism, inflammation, and the mitochondria (Figure 8G, Table S8). Interestingly, the GSEA analysis showed that GO terms and pathways affected by NMP in cCSP hearts were dominated by ribosomal function, transcription, and translation (11 and 5 of the 15 most affected GO terms and canonical pathways, respectively; Figure 8H, Tables S9 and S10). DISCUSSION This study demonstrates that controlled hypothermic (4 °C–8 °C) preservation of DCD hearts before NMP maintains graft function, metabolic integrity, and structural preservation at levels comparable to the current clinical standard of immediate NMP following procurement. These findings challenge the prevailing assumption that any delay between DCD procurement and reperfusion is inherently harmful, which is further challenged by the results from other groups that have demonstrated successful procurement and direct implantation of DCD grafts using a hyperoxygenated blood–del Nido flush. 47 However, to further support a potential paradigm shift toward a simpler, more flexible, and potentially more scalable strategy for preservation and evaluation of donated DCD hearts, rigorous scientific studies are needed to determine the ideal composition of the aortic flush, as different formulations (ie, hyperoxygenated blood–del Nido versus del Nido alone) appear to yield comparable results to immediate NMP. 48 A notable strength of controlled hypothermic storage is the logistical flexibility it introduces. Unlike the DPP approach, which requires immediate reperfusion and reliance on expensive, portable NMP devices, controlled cold storage allows for organ transport without an active perfusion system, significantly reducing cost, personnel demands, and time sensitivity. Although NMP in this study was implemented purely for graft assessment and will likely not be necessary clinically after further validation in transplant models, this preservation modality allows for flexible implementation of NMP at recipient centers following hypothermic storage, tailored to specific clinical needs. Reanimation at the recipient center enables the use of more sophisticated ex vivo assessment platforms, including physiological loading, to better evaluate graft viability before transplantation. 29 Furthermore, the combination of controlled hypothermic storage with subsequent NMP assessment resulted in an important extension of out‐of‐body time, which permitted an unprecedented 12 hours (1 hour instrumentation+7 cCSP+4 NMP) without any loss in metabolic fitness (Figure 2) or function (Figure 3). This unintended yet impactful outcome has the potential to address a second major hurdle in the field of organ transplantation: the persistent organ shortage crisis, by enabling broader geographic sharing, reducing discard rates, and increasing the overall pool of transplantable hearts. In addition to its logistical advantages, controlled hypothermia also appears to induce a state of reduced protein synthesis even after reanimation and 4 hours of NMP. In terms of immune activation, controlled hypothermia may contribute to delayed immune recognition and lower acute rejection risk posttransplant, as an important downregulation in the protein expression of a wide array of immune‐related genes was seen after NMP in both minimal CIT grafts and grafts stored in cCSP (Table S2, Figures S2 and S4). However, a larger number of key components of the complement system saw their expression reduced in cCSP grafts after NMP compared with minimal CIT grafts, including complement factor I, heparin cofactor II (Serpin Family E Member 1), and prothrombin. Likewise, several acute‐phase proteins were reduced after reperfusion in cCSP grafts but not in minimal CIT grafts, such as SERPINA1, fibrinogen chains FGA, FGB, and FGG, and haptoglobin, all of which play significant roles in immune activation and inflammatory responses. 49 , 50 This suppression of immunogenicity by hypothermic preservation could potentially minimize the risk of immune‐mediated injury, as its inhibition has been associated with reduced likelihood of graft rejection after transplantation in other organs. 51 In parallel, hypothermic preservation also led to the downregulation of several transcriptional regulators involved in driving inflammatory gene expression. Specifically, proteins, such as general thyroid hormone receptor‐associated protein 3, nuclear factor 1, and KH‐type splicing regulatory protein, which collectively influence the activation and stability of proinflammatory transcripts, including cytokines and complement factors, were significantly suppressed in cCSP‐preserved hearts. The attenuation of these regulators may contribute to the observed decline in inflammatory protein expression, reinforcing the concept of hypothermia‐induced immune quiescence. The effects of the reduction of these proteins can be seen in the significant reduction of the interleukin‐mediated inflammatory response associated with ischemia–reperfusion injury, 52 as evidenced by the decreased accumulation of select proinflammatory mediators, such as interleukin‐1 receptor antagonist and interleukin‐12, in grafts preserved under controlled hypothermia (Figure 6). In conjunction, these gene suppressions can likely create a low‐immunogenic, low‐inflammatory profile, which may contribute to delayed immune recognition and lower acute rejection risk posttransplant. Although the downregulation of inflammatory and immune pathways during hypothermic storage likely contributes to reduced graft immunogenicity, the sustained suppression of genes critical for cardiac function may hinder posttransplant recovery. Persistent downregulation of key contractile and structural proteins, such as myosin‐6, myosin light chain kinase, and myosin light chain 12A, may impair the reestablishment of myocardial contractility, limiting the heart's ability to generate sufficient force under postreperfusion stress. 53 , 54 However, GSEA shows that the gene set structural constituent of cytoskeleton is enriched in cCSP hearts after NMP, with cytoskeletal‐associated proteins driving this enrichment (eg, desmin, tubulin β 3, and desmoplakin, which are not expressed by circulating cells). Similarly, reduced expression of proteins involved in cardioprotective signaling, cellular repair, and mitochondrial dynamics (mitogen‐activated protein kinase, catenin β‐1, and dynamin‐1‐like protein), could delay adaptive responses required for recovery from ischemia–reperfusion injury. On the other hand, GSEA revealed that the gene set monoatomic cation transmembrane transporter activity was enriched in cCSP grafts, driven by SURF1, a protein involved in cytochrome c oxidase assembly (complex IV of the electron transport chain), mitochondrially encoded cytochrome b, a core protein of complex III of the electron transport chain, and a gene encoded by mitochondrial DNA, NADH ubiquinone oxidoreductase subunit A8, part of complex I of the electron transport chain. Although immune quiescence is a desired effect of hypothermic storage, a timely reactivation of essential contractile, metabolic, and repair pathways is likely critical for full functional reanimation and long‐term graft viability. As lesser‐known adverse effects of cold storage, such as protein downregulation, are increasingly recognized, greater attention must be given to the temperatures at which organs are preserved. Slightly higher storage temperatures may be more beneficial than conventional static cold storage (0 °C–4 °C), offering effective preservation while potentially allowing for the reversible suspension of organ functions. Excessive cooling, such as that seen during conventional static cold storage, has been shown to exacerbate inflammatory responses, increase structural damage on reperfusion, and contribute to adverse posttransplant events. 42 , 55 , 56 Although a downregulation of proteins key to myocardial function is observed in this study, it is interesting to note that gene sets related to protein synthesis are enriched in cCSP grafts after NMP, including translation, RNA processes, and ribosomal functions (Tables S9 and S10). In fact, 11 of the top 15 GO terms were related to protein synthesis in cCSP grafts, whereas only 6 were found in minimal CIT grafts. This suggests that there is more protein synthesis in cCSP grafts when compared with minimal CIT grafts. This underscores the importance of precise temperature control, which may provide a more favorable balance between metabolic suppression and organ integrity. While not unexpected, it is important to note that the heightened inflammatory response NMP seems to modulate in both minimal CIT and cCSP hearts, with both proinflammatory and anti‐inflammatory markers exhibiting up to a thousand‐fold increase at the end of 4 hours of perfusion when compared with initial perfusion time (Figure 6), consistent with findings reported in other studies. 33 , 57 Similarly, NMP appears to cause an important deterioration in the structural integrity of ventricular tissue, as observed in hematoxylin and eosin–stained images (Figure 4), not evident in the tissue postpreservation/preperfusion. Although cytoplasmic vacuolation can possibly be attributed to ischemia, 58 interstitial edema and vascular congestion are likely consequences of the inflammatory milieu generated during perfusion and the nonphysiological conditions of NMP. 59 Another challenging aspect of the experimental setup used in this study was replicating circulatory death in the porcine model. Swine hearts are known to exhibit a heightened sensitivity to ischemia compared with human hearts, which presents a unique limitation in the direct translation of human protocols into swine experimental models. 60 This increased vulnerability is largely attributed to the pig myocardium's higher metabolic rate and reduced ischemic tolerance, leading to a faster onset of irreversible myocardial damage. 61 , 62 As a result, even brief periods of warm ischemia can significantly impair cardiac function in pigs. 63 , 64 Therefore, although the onset of fWIT in humans is typically defined by a sustained systolic blood pressure of <50 mm Hg, 65 systemic oxygen saturation is often disregarded because of the unreliability of measurements in the absence of pulsatile flow. However, systemic oxygen saturation at the onset of fWIT may be critical to the success of the model and should not be overlooked in porcine studies, as systemic oxygen saturation values below ≈70% at the initiation of the 19‐minute fWIT have been associated with nonreanimatable grafts (Table S11). LIMITATIONS This study has several limitations. First, although the ex vivo platform used allows for detailed physiological assessment, only the left ventricle was loaded. As a result, functional evaluation of the right ventricle was limited. This represents a significant gap, particularly in the context of DCD transplantation, where the right ventricle is known to be more vulnerable to ischemia–reperfusion injury and often exhibits a higher incidence of early posttransplant failure. Second, although this study focused on early reperfusion and assessment end points, posttransplant function or survival was not evaluated. Therefore, a full transplant, longitudinal experimental setup would provide more comprehensive insight into biventricular performance, immune activation, and longer‐term outcomes, crucial to confirming these findings and assessing the true clinical utility of this strategy. Last, the results for GO and GSEA must be interpreted carefully because of the lower n value for minimal CIT hearts versus cCSP. Furthermore, the addition of blood proteome to the myocardium proteome during NMP makes it difficult to determine if the identified differentially abundant proteins are attributable to the addition of blood or to the myocardium's response to NMP. In fact, the analyses of GO and pathway annotations (Tables S3–S6) shows that GO terms related to blood are dominant (eg, extracellular space, blood microparticle, oxygen binding, platelet degranulation, and hemostasis). However, as red blood cells are devoid of intracellular organelles, the enrichment of ribosome and mitochondria proteins are likely because of changes in the myocardium proteome. This can also be inferred when looking at the GSEA, where terms unrelated to blood are dominant, including protein synthesis (ribosome and eukaryotic translation elongation), transporter activity, mitochondrial function (cristae formation and mitochondrial protein import), and inflammatory response (myeloid leukocyte migration and interleukin‐4 and interleukin‐13 signaling). Because GSEA offers a more comprehensive picture of changes in the proteome, it is important to consider its results alongside annotation analyses to capture both subtle and pronounced biological shifts. CONCLUSIONS The results in this study demonstrate that DCD hearts preserved under moderate hypothermia for up to 7 hours retain functional, structural, and metabolic viability equivalent to those reperfused immediately. This approach offers a logistically simpler and more cost‐effective alternative to current DPP practices, with the potential to reduce inflammation and preserve mitochondrial integrity. These findings support a reevaluation of existing DCD heart preservation protocols and lay the groundwork for further translational studies aimed at optimizing heart transplant logistics and outcomes. Sources of Funding This work was supported by generous funding to S.N.T. from the US National Institutes of Health (K99/R00 HL1431149 and R01HL157803). We also gratefully acknowledge funding from the US National Institute of Health (R01DK134590 and R24OD034189), National Science Foundation (EEC 1941543), American Heart Association (18CDA34110049), Harvard Medical School Eleanor and Miles Shore Fellowship, Polsky Family Foundation, the Claflin Distinguished Scholar Award on behalf of the MGH Executive Committee on Research, and Shriners Children's Boston (grant BOS‐85115). We also thankfully acknowledge support for S.A.R. Polsky Family Foundation. The electron microscopy was performed in the Microscopy Core of the Program in Membrane Biology, which is partially supported by NIH grant DK043351 and a Boston Area Diabetes and Endocrinology Research Center award DK135043. Disclosures The authors declare competing interests. D.V. is an employee and Founder of Ventri FLO Inc. S.N.T. has patent applications relevant to this study and serves on the Scientific Advisory Board for Sylvatica Biotech Inc, a company focused on developing organ preservation technology. Dr Rabi is provided funding by Paragonix Inc. S.N.T.'s and S.A.R.'s competing interests are managed by the MGH and Partners HealthCare in accordance with their conflict‐of‐interest policies. All other authors have no competing interests. Supporting information Data S1.